StratGraph
Companies / Financials
HOOD

Robinhood Markets

Investment Banking & Brokerage

Investment Banking & BrokerageAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health83
Growth100
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control50
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)11.8%Revenue growth (FY)51.6%Revenue CAGR (3y)48.8%Gross margin—Operating margin—Net margin42.1%Free cash flow margin36.6%R&D / revenue7.9%Stock comp / revenue6.8%Net debt / operating cash flow—Current ratio1.26Diluted share count change1.4%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$1.8B$1.4B$1.9B$3.0B$4.5B
Net income-$3.7B-$1.0B-$541M$1.4B$1.9B
Operating cash flow-$885M-$852M$1.2B-$157M$1.6B
Capital expenditure$63M$28M———
Free cash flow-$948M-$880M$1.2B-$157M$1.6B
R&D$438M$381M$349M$323M$355M
Stock-based comp$1.6B$654M$871M$304M$305M
Buybacks$0$0$608M$257M$653M
Cash$6.3B$6.3B$4.8B$4.3B$4.3B
Equity$7.3B$7.0B$6.7B$8.0B$9.2B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.